Literature DB >> 24551719

Piceatannol: a potential futuristic natural stilbene as fetal haemoglobin inducer.

Aayush Kukreja1, Samarth Tandon1, Amit Mishra1, Archana Tiwari1.   

Abstract

Beta thalassaemia is an autosomal recessive inherited blood disorder which results in abnormal formation of Haemoglobin molecule and ineffective erythropoiesis. Patients need to be dependent on habitual blood transfusion and on unaffordable exorbitant therapies for continued existence. It has been hypothesized that if the level of foetal Haemoglobin increases, it compensates the need of adult Haemoglobin and hence, ameliorates clinical symptoms associated with beta thalassaemia major. Illation from previous studies has proved that reactivation of foetal Haemoglobin with the aid of natural compounds is a better alternative therapy for patients of beta thalassaemia because of its cost effectiveness and occurrence in natural eatables. Piceatannol, a naturally occurring stilbene, is less studied compound in comparison to resveratrol, but it shows a wide range of biological activities. This article has mainly focused on piceatannol and its application as a foetal Haemoglobin inducer in future.

Entities:  

Keywords:  Beta thalassaemia; Foetal Haemoglobin inducer; Piceatannol; Stilbene

Year:  2013        PMID: 24551719      PMCID: PMC3919295          DOI: 10.7860/JCDR/2013/6239.3839

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  38 in total

1.  Piceatannol induces Fas and FasL up-regulation in human leukemia U937 cells via Ca2+/p38alpha MAPK-mediated activation of c-Jun and ATF-2 pathways.

Authors:  Wen-Hsin Liu; Long-Sen Chang
Journal:  Int J Biochem Cell Biol       Date:  2010-05-16       Impact factor: 5.085

2.  Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway.

Authors:  Elizabeth R Macari; Christopher H Lowrey
Journal:  Blood       Date:  2011-04-04       Impact factor: 22.113

Review 3.  Fetal globin induction in beta-thalassemia.

Authors:  Amal El-Beshlawy; Mona Hamdy; Mona El Ghamrawy
Journal:  Hemoglobin       Date:  2009       Impact factor: 0.849

4.  Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin.

Authors:  Ilaria Lampronti; Nicoletta Bianchi; Monica Borgatti; Eitan Fibach; Eugenia Prus; Roberto Gambari
Journal:  Eur J Haematol       Date:  2003-09       Impact factor: 2.997

5.  Stilbenes and oligostilbenes from leaf and stem of Vitis amurensis and their cytotoxic activity.

Authors:  Do Thi Ha; Quan Cheng Chen; Tran Manh Hung; Ui Joung Youn; Tran Minh Ngoc; Phuong Thien Thuong; Hong Jin Kim; Yeon Hee Seong; Byung Sun Min; Kihwan Bae
Journal:  Arch Pharm Res       Date:  2009-03-13       Impact factor: 4.946

6.  Rapamycin-mediated induction of gamma-globin mRNA accumulation in human erythroid cells.

Authors:  Carlo Mischiati; Alessia Sereni; Ilaria Lampronti; Nicoletta Bianchi; Monica Borgatti; Eugenia Prus; Eitan Fibach; Roberto Gambari
Journal:  Br J Haematol       Date:  2004-08       Impact factor: 6.998

7.  Interaction of the chemopreventive agent resveratrol and its metabolite, piceatannol, with model membranes.

Authors:  Olga Wesołowska; Michał Kuzdzał; Janez Strancar; Krystyna Michalak
Journal:  Biochim Biophys Acta       Date:  2009-06-13

8.  The Ethanol Extract of Fructus trichosanthis Promotes Fetal Hemoglobin Production via p38 MAPK Activation and ERK Inactivation in K562 Cells.

Authors:  Hui Li; Chun Hay Ko; Suk Ying Tsang; Ping Chung Leung; Ming Chui Fung; Kwok Pui Fung
Journal:  Evid Based Complement Alternat Med       Date:  2011-08-11       Impact factor: 2.629

9.  The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1.

Authors:  G A Potter; L H Patterson; E Wanogho; P J Perry; P C Butler; T Ijaz; K C Ruparelia; J H Lamb; P B Farmer; L A Stanley; M D Burke
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

10.  Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.

Authors:  Nicoletta Bianchi; Cristina Zuccato; Ilaria Lampronti; Monica Borgatti; Roberto Gambari
Journal:  Evid Based Complement Alternat Med       Date:  2007-12-11       Impact factor: 2.629

View more
  3 in total

1.  Complementary and alternative medicine use in thalassemia patients in Shiraz, southern Iran: A cross-sectional study.

Authors:  Mohammadreza Bordbar; Mehdi Pasalar; Sanaz Safaei; Roza Kamfiroozi; Sohelia Zareifar; Omidreza Zekavat; Sezaneh Haghpanah
Journal:  J Tradit Complement Med       Date:  2017-05-26

2.  Trans-Stilbenes in Commercial Grape Juices: Quantification Using HPLC Approaches.

Authors:  Julia López-Hernández; Ana Rodríguez-Bernaldo de Quirós
Journal:  Int J Mol Sci       Date:  2016-10-24       Impact factor: 5.923

3.  Piceatannol Suppresses the Proliferation and Induced Apoptosis of Osteosarcoma Cells Through PI3K/AKT/mTOR Pathway.

Authors:  Bin Wang; Jingyu Li
Journal:  Cancer Manag Res       Date:  2020-04-20       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.